19 studies found for:    Open Studies | "Urethral Diseases"
Show Display Options
Rank Status Study
1 Unknown  An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
Condition: Bladder Outlet Obstruction
Intervention: Drug: Toviaz (Fesoterodine)
2 Recruiting Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test
Conditions: Bladder Outlet Obstruction;   Pressure Flow Study
Intervention:
3 Recruiting Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms;   Neoplasms, Urethral;   Ureter Cancer;   Cancer of the Urethra;   Urethral Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Lenalidomide
4 Recruiting Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, and Urologic Cancers
Conditions: Healthy, no Evidence of Disease;   Localized Transitional Cell Cancer of the Renal Pelvis and Ureter;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Psychosocial Effects of Cancer and Its Treatment;   Recurrent Bladder Cancer;   Recurrent Cervical Cancer;   Recurrent Colon Cancer;   Recurrent Gastric Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Recurrent Uterine Sarcoma;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage II Bladder Cancer;   Stage II Renal Cell Cancer;   Stage II Urethral Cancer;   Stage IIA Cervical Cancer;   Stage IIA Colon Cancer;   Stage IIA Gastric Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIA Pancreatic Cancer;   Stage IIA Rectal Cancer;   Stage IIA Uterine Sarcoma;   Stage IIB Cervical Cancer;   Stage IIB Colon Cancer;   Stage IIB Gastric Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIB Pancreatic Cancer;   Stage IIB Rectal Cancer;   Stage IIB Uterine Sarcoma;   Stage IIC Colon Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage IIC Rectal Cancer;   Stage III Bladder Cancer;   Stage III Pancreatic Cancer;   Stage III Renal Cell Cancer;   Stage III Urethral Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Gastric Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Rectal Cancer;   Stage IIIA Uterine Sarcoma;   Stage IIIB Cervical Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Gastric Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Rectal Cancer;   Stage IIIB Uterine Sarcoma;   Stage IIIC Colon Cancer;   Stage IIIC Gastric Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Rectal Cancer;   Stage IIIC Uterine Sarcoma;   Stage IV Bladder Cancer;   Stage IV Gastric Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IV Urethral Cancer;   Stage IVA Cervical Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Cervical Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer;   Stage IVB Uterine Sarcoma;   Ureter Cancer
Interventions: Other: educational intervention;   Behavioral: telephone-based intervention;   Procedure: quality-of-life assessment;   Other: questionnaire administration
5 Recruiting Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography (SONO-URETHRA)
Condition: Urethral Stricture Disease
Interventions: Radiation: Urografin 30%;   Radiation: NaCl 0,9 % in aqua
6 Recruiting The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction
Conditions: Prostatic Hyperplasia;   Urinary Bladder Neck Obstruction;   Cystitis, Interstitial
Intervention:
7 Not yet recruiting Mecillinam for Treatment of Genital Chlamydia Infection
Conditions: Chlamydia Trachomatis Infection;   Chlamydial Urethritis
Intervention: Drug: Pivmecillinamhydrochlorid
8 Unknown  Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy
Condition: Urethral Stricture
Interventions: Procedure: Internal urethrotomy;   Drug: Mitomycin C -  local injection
9 Recruiting Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage III Bladder Cancer;   Stage III Urethral Cancer;   Stage IV Bladder Cancer;   Stage IV Urethral Cancer;   Ureter Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: eribulin mesylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
10 Unknown  Diagnosis of Bladder Outlet Obstruction Using Dynamic Urine Vibration "Holter" in Comparison to Pressure Flow Study
Condition: Bladder Outlet Obstruction
Intervention: Device: Dynamic Urine Vibration "Holter"
11 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Prostate Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Stage IV Urethral Cancer;   Transitional Cell Carcinoma of the Bladder;   Ureter Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: placebo;   Biological: bevacizumab;   Other: laboratory biomarker analysis
12 Recruiting Cabozantinib for Advanced Urothelial Cancer
Conditions: Urethral Neoplasms;   Ureteral Neoplasms;   Urinary Bladder Neoplasms;   Kidney Neoplasms
Intervention: Drug: Cabozantinib
13 Unknown  Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced
Conditions: Urethritis;   Cervicitis;   Genital Mycoplasma Infection;   Chlamydia Trachomatis
Interventions: Drug: Azithromycin;   Drug: Doxycycline;   Drug: lymecycline
14 Recruiting Afatinib in Advanced Refractory Urothelial Cancer
Conditions: Distal Urethral Cancer;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Urethral Cancer;   Stage III Bladder Cancer;   Stage III Urethral Cancer;   Stage IV Bladder Cancer;   Stage IV Urethral Cancer;   Ureter Cancer
Interventions: Drug: afatinib dimaleate;   Other: laboratory biomarker analysis
15 Recruiting Chronic Inflammatory Condition of the Male Genital Tract
Condition: Urethritis
Intervention: Other: Sperm sample
16 Unknown  Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral Strictures
Condition: Urethral Strictures
Intervention: Procedure: Internal Urethrotomy
17 Recruiting Bladder Outlet Obstruction Observation Using Dynamic Urine Vibration "Holter"
Condition: Bladder Outlet Obstruction
Intervention: Device: Dynamic Urine Vibration "Holter"
18 Not yet recruiting Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence
Conditions: Bladder Exstrophy;   Urinary Incontinence
Intervention: Drug: MDC
19 Unknown  Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Drug: sunitinib malate;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: quality-of-life assessment

Indicates status has not been verified in more than two years